IL2 and malaria: Patients harboring both leishmanial and malarial parasites responded with an overall increase in type-1 and pro-inflammatory cytokine release, which partly reflected the effect elicited by VL (TNF, IFN-γ) and malaria (IL-2), and partly resulted from a synergistic interaction of the two diseases upon each other (IL-17A).